175 related articles for article (PubMed ID: 35637944)
21. Targeting TBK1 Attenuates LPS-Induced NLRP3 Inflammasome Activation by Regulating of mTORC1 Pathways in Trophoblasts.
Lee S; Shin J; Kim JS; Shin J; Lee SK; Park HW
Front Immunol; 2021; 12():743700. PubMed ID: 34858401
[TBL] [Abstract][Full Text] [Related]
22. Cancer-associated IDH mutations induce Glut1 expression and glucose metabolic disorders through a PI3K/Akt/mTORC1-Hif1α axis.
Liu X; Yamaguchi K; Takane K; Zhu C; Hirata M; Hikiba Y; Maeda S; Furukawa Y; Ikenoue T
PLoS One; 2021; 16(9):e0257090. PubMed ID: 34516556
[TBL] [Abstract][Full Text] [Related]
23. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
[TBL] [Abstract][Full Text] [Related]
24. Circular RNA circDENND4C facilitates proliferation, migration and glycolysis of colorectal cancer cells through miR-760/GLUT1 axis.
Zhang ZJ; Zhang YH; Qin XJ; Wang YX; Fu J
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2387-2400. PubMed ID: 32196590
[TBL] [Abstract][Full Text] [Related]
25. Chronic innate immune activation of TBK1 suppresses mTORC1 activity and dysregulates cellular metabolism.
Hasan M; Gonugunta VK; Dobbs N; Ali A; Palchik G; Calvaruso MA; DeBerardinis RJ; Yan N
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):746-751. PubMed ID: 28069950
[TBL] [Abstract][Full Text] [Related]
26. mTORC1 Inactivation Promotes Colitis-Induced Colorectal Cancer but Protects from APC Loss-Dependent Tumorigenesis.
Brandt M; Grazioso TP; Fawal MA; Tummala KS; Torres-Ruiz R; Rodriguez-Perales S; Perna C; Djouder N
Cell Metab; 2018 Jan; 27(1):118-135.e8. PubMed ID: 29275959
[TBL] [Abstract][Full Text] [Related]
27. S100A2 promotes glycolysis and proliferation via GLUT1 regulation in colorectal cancer.
Li C; Chen Q; Zhou Y; Niu Y; Wang X; Li X; Zheng H; Wei T; Zhao L; Gao H
FASEB J; 2020 Oct; 34(10):13333-13344. PubMed ID: 32816365
[TBL] [Abstract][Full Text] [Related]
28. Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathway.
Chen T; Ren Z; Ye LC; Zhou PH; Xu JM; Shi Q; Yao LQ; Zhong YS
Cancer Biol Ther; 2015; 16(2):244-52. PubMed ID: 25602156
[TBL] [Abstract][Full Text] [Related]
29. BRIX1 promotes ribosome synthesis and enhances glycolysis by selected translation of GLUT1 in colorectal cancer.
Jiang C; Sun L; Wen S; Tian Y; Xu C; Xu Q; Xue H
J Gene Med; 2024 Jan; 26(1):e3632. PubMed ID: 38282151
[TBL] [Abstract][Full Text] [Related]
30. The GLUT1-mTORC1 axis affects odontogenic differentiation of human dental pulp stem cells.
Liu L; Xie H; Zhao S; Huang X
Tissue Cell; 2022 Jun; 76():101766. PubMed ID: 35286973
[TBL] [Abstract][Full Text] [Related]
31. A review on the role of TANK-binding kinase 1 signaling in cancer.
Alam M; Hasan GM; Hassan MI
Int J Biol Macromol; 2021 Jul; 183():2364-2375. PubMed ID: 34111484
[TBL] [Abstract][Full Text] [Related]
32. m
Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
[TBL] [Abstract][Full Text] [Related]
33. Exopolysaccharides isolated from Rhizopus nigricans induced colon cancer cell apoptosis in vitro and in vivo via activating the AMPK pathway.
Lu Y; Zhang X; Wang J; Chen K
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894839
[TBL] [Abstract][Full Text] [Related]
34. mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition.
Bhaskar PT; Nogueira V; Patra KC; Jeon SM; Park Y; Robey RB; Hay N
Mol Cell Biol; 2009 Sep; 29(18):5136-47. PubMed ID: 19620286
[TBL] [Abstract][Full Text] [Related]
35. WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1.
Henriques AFA; Matos P; Carvalho AS; Azkargorta M; Elortza F; Matthiesen R; Jordan P
Arch Biochem Biophys; 2020 Jan; 679():108223. PubMed ID: 31816312
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells.
Zhou MY; Cheng ML; Huang T; Hu RH; Zou GL; Li H; Zhang BF; Zhu JJ; Liu YM; Liu Y; Zhao XK
World J Gastroenterol; 2021 Oct; 27(40):6908-6926. PubMed ID: 34790014
[TBL] [Abstract][Full Text] [Related]
37. Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling.
Lin Y; Wu C; Wang X; Liu S; Zhao K; Kemper T; Yu H; Li M; Zhang J; Chen M; Zhu Y; Chen X; Lu M
Autophagy; 2020 Mar; 16(3):548-561. PubMed ID: 31204557
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth.
Padi SKR; Singh N; Bearss JJ; Olive V; Song JH; Cardó-Vila M; Kraft AS; Okumura K
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20505-20510. PubMed ID: 31548394
[TBL] [Abstract][Full Text] [Related]
39. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells.
Din FV; Valanciute A; Houde VP; Zibrova D; Green KA; Sakamoto K; Alessi DR; Dunlop MG
Gastroenterology; 2012 Jun; 142(7):1504-15.e3. PubMed ID: 22406476
[TBL] [Abstract][Full Text] [Related]
40. Foxp3 and Toll-like receptor signaling balance T
Gerriets VA; Kishton RJ; Johnson MO; Cohen S; Siska PJ; Nichols AG; Warmoes MO; de Cubas AA; MacIver NJ; Locasale JW; Turka LA; Wells AD; Rathmell JC
Nat Immunol; 2016 Dec; 17(12):1459-1466. PubMed ID: 27695003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
